MicroRNAs as outcome predictors in patients with metastatic colorectal cancer treated with bevacizumab in combination with FOLFOX

Bevacizumab is a humanized anti-vascular endothelial growth factor monoclonal antibody, used in combination with a oxaliplatin-based chemotherapy in the treatment of metastatic colorectal cancer (mCRC). The aim of the present study was to identify microRNA (miRNA)-based predictive biomarkers of ther...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Oncol Lett
Main Authors: Kiss, I., Mlčochová, J., Součková, K., Fabian, P., Poprach, A., Halamkova, J., Svoboda, M., Vyzula, R., Slaby, O.
Format: Artigo
Sprog:Inglês
Udgivet: D.A. Spandidos 2017
Fag:
Articles
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5494676/
https://ncbi.nlm.nih.gov/pubmed/28693229
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2017.6255
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker